SAFETY AND EFFICACY

Clinical trials for SAFETY AND EFFICACY explained in plain language.

Never miss a new study

Get alerted when new SAFETY AND EFFICACY trials appear

Sign up with your email to follow new studies for SAFETY AND EFFICACY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1

Double-Target immune cell therapy tested for aggressive blood cancer

Disease control Ongoing

This study tests a two-pronged immune cell therapy for adults with high-risk multiple myeloma, a serious blood cancer. After receiving their own stem cell transplant, patients get specially modified T-cells designed to attack cancer by targeting two proteins (CD19 and BCMA). Rese…

Matched conditions: SAFETY AND EFFICACY

Phase: PHASE1, PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

SAFETY AND EFFICACY

Get alerted when new SAFETY AND EFFICACY trials appear

Double-Target immune cell therapy tested for aggressive blood cancer